565 related articles for article (PubMed ID: 18234542)
21. Interaction between tumour necrosis factor-α gene polymorphisms and substance use on risk of betel quid-related oral and pharyngeal squamous cell carcinoma in Taiwan.
Yang CM; Hou YY; Chiu YT; Chen HC; Chu ST; Chi CC; Hsiao M; Lee CY; Hsieh CJ; Lin YC; Hsieh YD; Ger LP
Arch Oral Biol; 2011 Oct; 56(10):1162-9. PubMed ID: 21497332
[TBL] [Abstract][Full Text] [Related]
22. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
[TBL] [Abstract][Full Text] [Related]
23. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
Drummond SN; De Marco L; Pordeus Ide A; Barbosa AA; Gomez RS
Anticancer Res; 2002; 22(6A):3379-81. PubMed ID: 12530090
[TBL] [Abstract][Full Text] [Related]
24. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan.
Tseng HC; Tsai MH; Chiu CF; Wang CH; Chang NW; Huang CY; Tsai CW; Liang SY; Wang CL; Bau DT
Anticancer Res; 2008; 28(3A):1687-91. PubMed ID: 18630527
[TBL] [Abstract][Full Text] [Related]
25. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
27. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
[TBL] [Abstract][Full Text] [Related]
28. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
Bathi RJ; Prabhat
Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
[TBL] [Abstract][Full Text] [Related]
29. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan.
Wu MT; Chen MC; Wu DC
Cancer Lett; 2004 Mar; 205(1):61-8. PubMed ID: 15036662
[TBL] [Abstract][Full Text] [Related]
30. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential.
Szarka K; Tar I; Fehér E; Gáll T; Kis A; Tóth ED; Boda R; Márton I; Gergely L
Oral Microbiol Immunol; 2009 Aug; 24(4):314-8. PubMed ID: 19572894
[TBL] [Abstract][Full Text] [Related]
31. p53 Codon 72 polymorphism in oral exfoliated cells in a Sudanese population.
Sand L; Jalouli MM; Jalouli J; Sapkota D; Ibrahim SO
In Vivo; 2012; 26(1):59-62. PubMed ID: 22210716
[TBL] [Abstract][Full Text] [Related]
32. Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array.
Luo CW; Roan CH; Liu CJ
Int J Oral Maxillofac Surg; 2007 Feb; 36(2):153-8. PubMed ID: 17110084
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
34. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation.
Pandey M; Prakash O; Santhi WS; Soumithran CS; Pillai RM
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):379-83. PubMed ID: 18356024
[TBL] [Abstract][Full Text] [Related]
36. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis.
Chen YJ; Chang JT; Liao CT; Wang HM; Yen TC; Chiu CC; Lu YC; Li HF; Cheng AJ
Cancer Sci; 2008 Aug; 99(8):1507-14. PubMed ID: 18754860
[TBL] [Abstract][Full Text] [Related]
37. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
[TBL] [Abstract][Full Text] [Related]
38. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma.
Liu CJ; Wong YK; Chang KW; Chang HC; Liu HF; Lee YJ
J Oral Pathol Med; 2005 Nov; 34(10):608-12. PubMed ID: 16202081
[TBL] [Abstract][Full Text] [Related]
40. Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese.
Goan YG; Chang HC; Hsu HK; Chou YP; Cheng JT
Cancer Sci; 2005 Nov; 96(11):758-65. PubMed ID: 16271069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
